Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
38,501,580
-
Share change
-
-1,550,909
-
Total reported value
-
$4,708,254,943
-
Put/Call ratio
-
388%
-
Price per share
-
$122.29
-
Number of holders
-
817
-
Value change
-
-$193,364,356
-
Number of buys
-
220
-
Number of sells
-
383
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2023
As of 30 Sep 2023 ISHARES TR - ISHARES BIOTECH (IBB) had 817 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,501,580 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, UBS Group AG, BNP PARIBAS ARBITRAGE, SNC, Royal Bank of Canada, COMMERCE BANK, and WELLS FARGO & COMPANY/MN.
This table shows 830 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.